Yoon G. Ko
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Selective Targeting of Tip Endothelial Cells as a Therapeutic Strategy for Tumor Angiogenesis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 15, 2025
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 18, 2024
Macropinocytosis-targeted peptide-docetaxel conjugate for bystander pancreatic cancer treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 22, 2024
Synergistic anticancer immunity in metastatic triple-negative breast cancer through an in situ amplifying Peptide-Drug Conjugate.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 25, 2024
Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 09, 2024
Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide-drug conjugate therapy in metastatic triple-negative breast cancer.
Journal: Biomaterials
Published: May 05, 2022
Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 14, 2022
Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 27, 2021
Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer.
Journal: Biomaterials
Published: February 09, 2021
Triazole-Coupled Benzimidazole-Based Fluorescent Sensor for Silver, Bromide, and Chloride Ions in Aqueous Media.
Journal: Journal of fluorescence
Published: April 03, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026